Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review

Khatri, Akshay; Wallach, Frances

doi:10.1016/j.hrtlng.2020.06.003

Cited by 29 publications

(50 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Usually, cardiovascular involvement in COVID-19 patients has been described as myocardial injury identified by troponin increase [11][12][13][14], thus a precise morphological and functional characterization of the heart in COVID-19 patients with clinically suspected myocarditis is lacking on a large scale. Nearly all the information about myocarditis in these patients comes from case reports or small series [15][16][17][18][19][20][21], which have been included in 3 systematic reviews so far [15][16][17].…”

Section: Prevalence Characteristics and Prognosis Of Myocarditis Inmentioning

confidence: 99%

Myocarditis in COVID-19 patients: current problems

et al. 2021

View full text Add to dashboard Cite

Myocarditis has been reported as a possible clinical presentation or complication in patients with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this possibility generated among physicians, there is paucity of information about mechanisms, prevalence, prognosis, diagnosis and therapy of myocarditis in the context of COVID-19. This brief review has the goal to revise and summarize current knowledge on myocarditis in COVID-19 patients and underline problems especially related to diagnosis and treatment.

show abstract

Section: Prevalence Characteristics and Prognosis Of Myocarditis Inmentioning

confidence: 99%

Myocarditis in COVID-19 patients: current problems

et al. 2021

View full text Add to dashboard Cite

show abstract

“…COVID-19 has been associated with myopericarditis in case studies, 1 , 2 , 3 , 4 and myocardial injury has been associated with increased morbidity and mortality. 5 , 6 Large studies using biopsy, histologic examination, and molecular-based testing for the severe acute respiratory syndrome coronavirus 2 genome in cardiac tissue are needed to illuminate the potential role of COVID-19 in myopericarditis.…”

Section: Diagnosismentioning

confidence: 97%

Young Man With Shortness of Breath

Hodson

Reinhardt

Moore

2021

Annals of Emergency Medicine

View full text Add to dashboard Cite

“…In the rest of the cases, the most reported laboratory blood tests included different combinations of troponin T, Troponin I, N-terminal pro b-type natriuretic peptide (NT-proBNP), and C-Reactive Protein (CRP), all of which, when done, were consistently elevated. Some cases also reported CK-MB levels as high [11,14,23,30,35]. One case reported an elevated serum myoglobin level [17].…”

Section: B) Laboratory Blood Testsmentioning

confidence: 99%

“…Other patients' ECGs showed non-specific ischemic changes such as T-wave inversions [11,26]. Tachyarrhythmias, mainly sinus tachycardia, was noted [17,18,25,28,30,34], as well as ventricular tachycardia and atrial fibrillation [2,19].…”

Section: Diagnostic Testing A) Ecg Findingsmentioning

confidence: 99%

COVID-19 Myocarditis Clinical Presentation, Diagnosis and Management: A Narrative Review

Zaghrini¹,

Emmanuel²,

Zibara³

et al. 2021

Int J Clin Res

View full text Add to dashboard Cite

Objective: The purpose of this article is to review the cases of myocarditis in COVID-19 patients and synthesize the current understanding regarding the presentation, diagnosis, and management of myocarditis in the setting of COVID-19 disease. Background: The novel coronavirus disease has shown serious implications for the cardiovascular system, including acute myocardial injury, arrhythmias, venous thromboembolism, and myocarditis. Several cases of myocarditis in COVID-19 patients have been reported since the disease's emergence at the end of 2019. The diagnostic approach and management have been variable. The purpose of this narrative review is to gather the most reliable published material regarding myocarditis in COVID-19 and present it as an overview to simplify the current understanding we have of this disease. Methods: We screened PubMed, Scopus, and Embase. We then selected peer-reviewed and pre-print articles published in English that were related to the involvement of the cardiovascular system in COVID-19, with a focus on myocarditis. We included case reports describing myocarditis in COVID-19 patients and summarized their clinical presentation, diagnosis, and management. References of the selected articles were also screened, and some were included when relevant. Discussion: This article is subdivided into sections that discuss the clinical presentation of COVID-19 myocarditis and move on to various diagnostic approaches and management options. Each subsection presents a brief literature review followed by a summary and interpretation of what was found in the reported cases. Conclusion: After noticing the involvement of the cardiovascular system in COVID-19 patients, specifically through myocarditis, we present this narrative review to provide the medical community with a unified article regarding the current understanding of myocarditis in COVID-19 patients. This article further stresses the necessity of establishing proper treatment guidelines for COVID-19 myocarditis.

show abstract

Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review

Cited by 29 publications

References 30 publications

Myocarditis in COVID-19 patients: current problems

Myocarditis in COVID-19 patients: current problems

Young Man With Shortness of Breath

COVID-19 Myocarditis Clinical Presentation, Diagnosis and Management: A Narrative Review

Contact Info

Product

Resources

About